FTO and breast cancer: As shown in Figure 3(a-d), the introduction of FTO shRNAs weakened the mRNA and protein expression of FTO in BC-DoxR cells and plasmids overexpressing FTO increased the mRNA and protein expression of FTO in BC cells.